CK-MM autoantibodies: Prevalence, immune complexes, and effect on CK clearance

Muscle and Nerve

Volumn 34, Issue 3, 2006, Pages 335-346

  Warren, Gordon L ^a   O'Farrell, Laura ^b   Rogers, Karen R ^a   Billings, Kelly M ^a   Sayers, Stephen P ^c   Clarkson, Priscilla M ^d  

^a GEORGIA STATE UNIVERSITY   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

^d UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

Autoantibodies; Creatine kinase; Immune complex; Immunoglobulin; Muscle injury

Indexed keywords

AUTOANTIBODY; CREATINE KINASE MM; PROTEIN A; SEPHAROSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME METABOLISM; FEMALE; HUMAN; INDIVIDUALITY; MALE; MOUSE; MUSCLE INJURY; NONHUMAN; PRIORITY JOURNAL;

ADULT; ANIMALS; ANTIGEN-ANTIBODY COMPLEX; AUTOANTIBODIES; CREATINE KINASE, MM FORM; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SKELETAL; MYOSITIS; NERVOUS SYSTEM AUTOIMMUNE DISEASE, EXPERIMENTAL; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; SEROEPIDEMIOLOGIC STUDIES;

EID: 33748064376     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.20594     Document Type: Article

References (49)

1. Abbott LB, Van Lente F. Procedure for characterization of creatine kinase variants on agarose electrophoretograms. Clin Chem 1985;31:445-447.
2. Bauer K, Bayer PM, Deutsch E, Gabi F. Binding of enzyme-IgG complexes in human serum to protein-A sepharose CL-4B. Clin Chem 1980;26:297-300.
3. Bijsterbosch MK, Duursma AM, Smit MJ, Bos OJ, Bouma JM, Gruber M. Several dehydrogenases and kinases compete for endocytosis from plasma by rat tissues. Biochem J 1985;229:409-417.
4. Clarkson PM, Ebbeling C. Investigation of serum creatine kinase variability after muscle-damaging exercise. Clin Sci (Lond) 1988;75:257-261.
5. Clarkson PM, Hoffman EP, Zambraski E, Gordish-Dressman H, Kearns A, Hubal M, et al. ACTN3 and MLCK genotype associations with exertional muscle damage. J Appl Physiol 2005;99:564-569.
6. Clarkson PM, Nosaka K, Braun B. Muscle function after exercise-induced muscle damage and rapid adaptation. Med Sci Sports Exerc 1992;24:512-520.
7. Delanghe J, De Scheerder I, De Buyzere M, Algoed L, Robbrecht J. Macro CK type 1 as a marker for autoimmunity in coronary heart disease. Atherosclerosis 1986;60:215-219.
8. Ebbeling CB, Clarkson PM. Muscle adaptation prior to recovery following eccentric exercise. Eur J Appl Physiol Occup Physiol 1990;60:26-31.
9. Fairweather D, Rose NR. Women and autoimmune diseases. Emerg Infect Dis 2004;10:2005-2011.
10. Finbloom DS, Magilavy DB, Harford JB, Rifai A, Plotz PH. Influence of antigen on immune complex behavior in mice. J Clin Invest 1981;68:214-224.
11. Fritzler MJ. Clinical relevance of autoantibodies in systemic rheumatic diseases. Mol Biol Rep 1996;23:133-145.
12. Hengstman GJ, van Engelen BG, van Venrooij WJ. Myositis specific autoantibodies: changing insights in pathophysiology and clinical associations. Curr Opin Rheumatol 2004;16:692-699.
13. Hyatt JP, Clarkson PM. Creatine kinase release and clearance using MM variants following repeated bouts of eccentric exercise. Med Sci Sports Exerc 1998;30:1059-1065.
14. Ishise S, Pegram BL, Yamamoto J, Kitamura Y, Frohlich ED. Reference sample microsphere method: cardiac output and blood flows in conscious rat. Am J Physiol 1980;239:H443-H449.
15. Kanemitsu F, Okigaki T. An immunologic pathway for intravascular catabolism of creatine kinase subform MM3. Clin Chim Acta 1991;197:9-17.
16. Kiechle FL, Quattrociocchi-Longe TM, Brinton DA, Gordon SC, Sykes E, Elkhalifa MY. Autoantibodies to specific enzymes: a review. Ann Clin Lab Sci 1996;26:195-207.
17. Kosugi I, Muro H, Shirasawa H, Ito I. Endocytosis of soluble IgG immune complex and its transport to lysosomes in hepatic sinusoidal endothelial cells. J Hepatol 1992;16:106-114.
18. Langone JJ. Applications of immobilized protein A in immunochemical techniques. J Immunol Methods 1982;55:277-296.
19. Lebrec D, Blanchet L, Lacroix S. Measurement of hepatic blood flow in the rat using fractional clearance of indocyanine green and colloidal radiogold. Pflügers Arch 1981;391:353-354.
20. Lee KN, Csako G, Bernhardt P, Elin RJ. Relevance of macro creatine kinase type 1 and type 2 isoenzymes to laboratory and clinical data. Clin Chem 1994;40:1278-1283.
21. Mimori T. Structures targeted by the immune system in myositis. Curr Opin Rheumatol 1996;8:521-527.
22. Morris GE, Cartwright AJ. Monoclonal antibody studies suggest a catalytic site at the interface between domains in creatine kinase. Biochim Biophys Acta 1990;1039:318-322.
23. Morris GE, Frost LC, Newport PA, Hudson N. Monoclonal antibody studies of creatine kinase. Antibody-binding sites in the N-terminal region of creatine kinase and effects of antibody on enzyme refolding. Biochem J 1987;248:53-59.
24. Nagashima T, Kamegai M, Hirose K, Yamada K, Uono M, Tsubaki T, et al. Creatine kinase (CK)-linked IgA in Isaacs' syndrome. An immune complex disease? J Neurol Sci 1985; 67:269-276.
25. Newham DJ, Jones DA, Clarkson PM. Repeated high-force eccentric exercise: effects on muscle pain and damage. J Appl Physiol 1987;63:1381-1386.
26. Nosaka K, Clarkson PM. Effect of eccentric exercise on plasma enzyme activities previously elevated by eccentric exercise. Eur J Appl Physiol Occup Physiol 1994;69:492-497.
27. Pankuweit S, Lottspeich F, Maisch B. Characterization of relevant membrane antigens by two-dimensional immunoblot and n-terminal sequence analysis in patients with myocarditis. Eur Heart J 1995;16(Suppl O):81-84.
28. Pankuweit S, Portig I, Lottspeich F, Maisch B. Autoantibodies in sera of patients with myocarditis: characterization of the corresponding proteins by isoelectric focusing and N-terminal sequence analysis. J Mol Cell Cardiol 1997;29:77-84.
29. Ranua J, Luoma K, Auvinen A, Peltola J, Haapala AM, Raitanen J, et al. Serum IgA, IgG, and IgM concentrations in patients with epilepsy and matched controls: a cohort-based cross-sectional study. Epilepsy Behav 2005;6:191-195.
30. Savers SP, Clarkson PM. Short-term immobilization after eccentric exercise. Part II. Creatine kinase and myoglobin. Med Sci Sports Exerc 2003;35:762-768.
31. Schifferli JA, Despont JP, Cruchaud A, Carpentier N, Jeannet M, Schmidt M. Macro-creatine kinase type 1. Immunological studies in 14 patients with comments on clinical significance. Arch Pathol Lab Med 1986;110:425-429.
32. Schubert D, Schmidt M, Zaiss D, Jungblut PR, Kamradt T. Autoantibodies to GPI and creatine kinase in RA. Nat Immunol 2002;3:411.
33. Skogh T, Blomhoff R, Eskild W, Berg T. Hepatic uptake of circulating IgG immune complexes. Immunology 1985;55:585-594.
34. Smit MJ, Duursma AM, Bouma JM, Gruber M. Receptor-mediated endocytosis of lactate dehydrogenase M4 by liver macrophages: a mechanism for elimination of enzymes from plasma. Evidence for competition by creatine kinase MM, adenylate kinase, malate, and alcohol dehydrogenase. J Biol Chem 1987;262:13020-I3026.
35. Stupka N, Tarnopolsky MA, Yardley NJ, Phillips SM. Cellular adaptation to repeated eccentric exercise-induced muscle damage. J Appl Physiol 2001;91:1669-1678.
36. Tontsch D, Pankuweit S, Maisch B. Autoantibodies in the sera of patients with rheumatic heart disease: characterization of myocardial antigens by two-dimensional immunoblotting and N-terminal sequence analysis. Clin Exp Immunol 2000;121:270-274.
37. Tozawa T. Enzyme-linked immunoglobulins and their clinical significance. Electrophoresis 1989;10:640-644.
38. Van der Meulen JH, Kuipers H, Drukker J. Relationship between exercise-induced muscle damage and enzyme release in rats. J Appl Physiol 1991;71:999-1004.
39. Versalovic J, Nash ZD, Carinhas R, Musher DM, Baughn RE. Immunoglobulin class and subclass restriction of autoimmune responses in secondary syphilis. Clin Exp Immunol 1990;80:381-386.
40. von Muhlen CA, Tan EM. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 1995;24:323-358.
41. Warren GL, FennessyJM, Millard-Stafford ML. Strength loss after eccentric contractions is unaffected by creatine supplementation. J Appl Physiol 2000;89:557-562l
42. Warren GL, Hermann KM, Ingalls CP, Masselli MR, Armstrong RB. Decreased EMG median frequency during a second bout of eccentric contractions. Med Sci Sports Exerc 2000;32:820-829.
43. Warren GL, Hulderman T, Jensen N, McKinstry M, Mishra M, Luster MI, et al. Physiological role of tumor necrosis factor alpha in traumatic muscle injury. FASEB J 2002;16:1630-1632.
44. Warren GL, Hulderman T, Mishra D, Gao X, Millecchia L, O'Farrell L, et al. Chemokine receptor CCR2 involvement in skeletal muscle regeneration. FASEB J 2005;19:413-415.
45. Warren GL, Ingalls CP, Shah SJ, Armstrong RB. Uncoupling of in vivo torque production from EMG in mouse muscles injured by eccentric contractions. J Physiol (Lond) 1999;515:609-619.
46. Warren GL, Lowe DA, Armstrong RB. Measurement tools used in the study of eccentric contraction-induced injury. Sports Med 1999;27:43-59.
47. Warren GL, O'Farrell L, Summan M, Hulderman T, Mishra D, Luster MI, et al. Role of CC chemokines in skeletal muscle functional restoration after injury. Am J Physiol Cell Physiol 2004;286:C1031-1036.
48. Webber LM, Byrnes WC, Rowland TW, Foster VL. Serum creatine kinase activity and delayed onset muscle soreness in prepubescent children: a preliminary study. Pediatr Exerc Sci 1989;1:351-359.
49. Yuu H, Ishizawa S, Takagi Y, Gomi K, Senju O, Ishii T. Macro creatine kinase: a study on CK-linked immunoglobulin. Clin Chem 1980;26:1816-1820.